Skip to Content

WATSON 3210 WATSON 3210 (Rivastigmine Tartrate 4.5 mg)

Pill with imprint WATSON 3210 WATSON 3210 is Brown, Capsule-shape and has been identified as Rivastigmine Tartrate 4.5 mg. It is supplied by Watson Pharmaceuticals.

Rivastigmine is used in the treatment of alzheimer's disease; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 4.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 3210 WATSON 3210

Rivastigmine tartrate 4.5 mg WATSON 3210 WATSON 3210
Rivastigmine tartrate 4.5 mg WATSON 3210 WATSON 3210
Rivastigmine tartrate 4.5 mg WATSON 3210 WATSON 3210
Rivastigmine tartrate 4.5 mg WATSON 3210 WATSON 3210

Rivastigmine Tartrate

Imprint:
WATSON 3210 WATSON 3210
Strength:
4.5 mg
Color:
Brown
Size:
18.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Cholinesterase inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals
Inactive Ingredients:

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC CodeLabeler / Repackager
00591-3210 Watson Pharmaceuticals, Inc.
63739-0578 McKesson Packaging Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide